Aptah Bio
PrivateLast Round
Seed
Dec 24, 2024
Total Funding Raised
$18M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Aptah Bio operates in Healthcare & Life Sciences and is based in San Carlos, California. Its latest recorded funding round was a Series A round in August 2023.
Aptah Bio is a biotechnology company that develops first-in-class RNA therapeutics targeting U1 snRNP dysfunction to slow tumor evolution, reduce cancer heterogeneity, and overcome adaptive resistance in glioblastoma and solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aptah Bio Comparables
Compare Aptah Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ceptur Therapeutics | 84% | |
| Skyhawk Therapeutics | 72% | |
| Inverna Therapeutics | 72% |
For institutional investors. Book with your work email.
Aptah Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 24, 2024 | ||||
| Series A | Aug 14, 2023 | ||||
| Accelerator | Aug 26, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Aptah Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Taihill Venture | Seed |
| 5Y Capital | Seed |
| K2VC | Seed |
| UpHonest Capital | Seed |
| Financiadora de Estudos e Projetos | Series A |
| Mission BioCapital | Series A |
| Vesper | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors increased 43% MoM.
- Aug 20, 2026
Monthly visitors grew 116% MoM, reaching 2K.
For institutional investors. Book with your work email.
Aptah Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Aptah Bio's valuation, stock price, and market status.
Is Aptah Bio a public or private company?
Aptah Bio is a private company.
What is the current stock price of Aptah Bio?
Aptah Bio is a private company, so its shares have no public market price. Caplight tracks Aptah Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Aptah Bio worth (valuation)?
Valuation information for Aptah Bio is not publicly available.
Can I buy Aptah Bio stock?
Aptah Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Aptah Bio's last funding round?
Aptah Bio's most recent funding round was Seed on December 24, 2024.
Who are the main investors in Aptah Bio?
Key investors in Aptah Bio include Taihill Venture, 5Y Capital, K2VC, UpHonest Capital, Financiadora de Estudos e Projetos.
Will Aptah Bio IPO soon?
No public IPO plans have been announced for Aptah Bio.
How can I track Aptah Bio secondary market activity?
Caplight tracks bids, offers, and trades in Aptah Bio's shares on secondary markets.